Trusted Identities in Blockchain Apps Shown to Work To Benefit Healthcare and Pharma

Blockchain Expo North America 2019

Share with:

A recently completed proof of concept study demonstrates that robust identity trust can be integrated with Blockchain technology. This development has significant implications for the use of distributed electronic ledgers (i.e., Blockchain) for pharmaceutical, healthcare and other applications.

advertisementToken Agency

The study was conducted by Peer Ledger, a Canadian Blockchain company, SAFE-BioPharma Association, the organization managing the global SAFE-BioPharma digital identity management standard and Synchronoss, a leading provider of standards-based digital identities.

“Blockchain – the technology underlying Bitcoin – has the power to disrupt traditional practices for drug discovery, patient engagement and monitoring, payments, and participatory healthcare delivery,” said Dawn Jutla, Ph.D., CEO and founder, Peer Ledger.

Blockchain technology deploys a shared, synchronized, distributed ledger of transactions, guaranteeing security and decreased fraud by providing a permanent record of who accessed ledgers and what they did.

The proof of concept showed that SAFE-BioPharma compliant digital identities can be linked to the Blockchain to assure trust in the identity of each person engaged in the transaction. Transactions can be anonymous until the completion of a clinical study or other project and subsequently “chained back” to the proven identity of the user if needed for regulatory or clinical purposes. Alternatively, the identities associated with each block can be known throughout the process, such as in track and trace applications for the medicines supply chain.

“Every SAFE-BioPharma compliant identity credential accurately represents the proven identity of the person using it. Teaming these credentials with anonymous Blockchain ledger postings enables use cases critical for overall cybersecurity across healthcare and the life sciences,” explained Mollie Shields Uehling, president and CEO, SAFE-BioPharma Association.

Prior to the study, identities associated with distributed electronic ledgers were entirely anonymous. The study shows that cyber identities that comply with the SAFE-BioPharma standard allow identities to be de-anonymized, a requirement for double-blinded clinical trials, audits and responsible supply chains.

Peer Ledger is a Blockchain company specializing in the pharmaceutical, healthcare and precious metal sectors. It offers an identity bridge product between public key infrastructure and Blockchain, and the Mimosi track-and-trace Blockchain product for responsible supply chains.

The SAFE-BioPharma standards for digital identity and digital signatures are used in life science and health care.

Synchronoss (NASDAQ:SNCR) is an innovative software company with simple, powerful and flexible solutions used by more than 3 billion mobile users and 300 of the Fortune 500 worldwide.

Share with:

About Richard Kastelein

Founder and publisher of industry publication Blockchain News (EST 2015), a partner at ICO services collective Token.Agency ($750m+ and 90+ ICOs and STOs), director of education company Blockchain Partners (Oracle Partner) – Vancouver native Richard Kastelein is an award-winning publisher, innovation executive and entrepreneur. He sits on the advisory boards of some two dozen Blockchain startups and has written over 1500 articles on Blockchain technology and startups at Blockchain News and has also published pioneering articles on ICOs in Harvard Business Review and Venturebeat. Irish Tech News put him in the top 10 Token Architects in Europe.

Kastelein has an Ad Honorem - Honorary Ph.D. and is Chair Professor of Blockchain at China's first Blockchain University in Nanchang at the Jiangxi Ahead Institute of Software and Technology. In 2018 he was invited to and attended University of Oxford's Saïd Business School for Business Automation 4.0 programme.  Over a half a decade experience judging and rewarding some 1000+ innovation projects as an EU expert for the European Commission's SME Instrument programme as a startup assessor and as a startup judge for the UK government's Innovate UK division.

Kastelein has spoken (keynotes & panels) on Blockchain technology in Amsterdam, Antwerp, Barcelona, Beijing, Brussels, Bucharest, Dubai, Eindhoven, Gdansk, Groningen, the Hague, Helsinki, London (5x), Manchester, Minsk, Nairobi, Nanchang, Prague, San Mateo, San Francisco, Santa Clara (2x), Shanghai, Singapore (3x), Tel Aviv, Utrecht, Venice, Visakhapatnam, Zwolle and Zurich.

He is a Canadian (Dutch/Irish/English/Métis) whose writing career has ranged from the Canadian Native Press (Arctic) to the Caribbean & Europe. He's written occasionally for Harvard Business Review, Wired, Venturebeat, The Guardian and, and his work and ideas have been translated into Dutch, Greek, Polish, German and French. A journalist by trade, an entrepreneur and adventurer at heart, Kastelein's professional career has ranged from political publishing to TV technology, boatbuilding to judging startups, skippering yachts to marketing and more as he's travelled for nearly 30 years as a Canadian expatriate living around the world. In his 20s, he sailed around the world on small yachts and wrote a series of travel articles called, 'The Hitchhiker's Guide to the Seas' travelling by hitching rides on yachts (1989) in major travel and yachting publications. He currently lives in Groningen, Netherlands where he's raising three teenage daughters with his wife and sailing partner, Wieke Beenen.

Visit Website
View All Articles
Blockchain Partners

Token Agency
Blockchain Expo North America 2019


This site uses Akismet to reduce spam. Learn how your comment data is processed.